Otago welcomes Simon Gwynn to the Otago team. “Simon has significant experience in working with Specialist Biopharmaceutical companies across Europe on market access and development of […]
Otago Healthcare plans participation in the 8 th Global Orphan Drug Congress in Maryland between April 24th -28th . “We believe this forum will be an […]
Otago Healthcare launches new website with strategic focus on working with Specialist Biopharmaceutical companies looking to commercialise their Orphan Drugs across Europe and the Middle East. […]
Otago welcomes Kay Drake to the Otago management team. Kay will be responsible for sales and marketing with key Orphan Drugs we will be commercialising in […]
Otago to attend the 8th Annual World Orphan Drug Congress European in Barcelona.” This congress is of vital importance for showcasing our unique commercial model for […]
Otago to attend the 4th International Conference on Drug Discovery in India as their will be key stakeholders and specialist pharma attending from key strategic markets […]
Otago appoint Andrew Hasker as Finance Director. “Andrew is a very experienced FD who has extensive global experience having worked with major US based companies with […]
Otago Healthcare will attend the 9th Biopharma Asia Convention in Singapore. “ This is a new opportunity for us to share the Otago model for market […]
Otago holds strategic meetings with specialist distributor of Orphan drugs for the Middle East. “Our discussions with our new partner for the Middle East have been […]
Otago Healthcare look to participate in the 3rd Annual Congress on Rare Diseases and Orphan Drugs in San Antonio. “This is an important forum for Otago […]